HHC
AGN.PRA

Hutchin Hill Capital’s Allergan plc AGN.PRA Stock Holding History

Hutchin Hill Capital’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,000
Closed -$4.13M – 864
2015
Q4 		$4.13M Buy
+4,000
New +$4.02M 0.1% 186

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hutchin Hill Capital's AGN.PRA Position: Q1 2016 in Review

Hutchin Hill Capital sold out of Allergan plc (AGN.PRA) in Q1 2016, closing a stake of 4,000 shares — an estimated $4.13M sold.

Hutchin Hill Capital first reported a position in AGN.PRA in Q4 2015 and held it in 1 quarter. The position peaked at $4.13M in Q4 2015. 103 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2016.

  • Hutchin Hill Capital reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Hutchin Hill Capital sold 4,000 Allergan plc shares in Q1 2016, an estimated $4.13M.
  • Hutchin Hill Capital first reported a position in Allergan plc in Q4 2015 and held it in 1 quarter.
  • Hutchin Hill Capital's Allergan plc position peaked at $4.13M in Q4 2015.
  • 103 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Hutchin Hill Capital's 13F filing for Q1 2016, filed 16 May 2016.